RICHMOND, VA – January 28, 2021 – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is conducting a formalized, competitive, one-time COVID-19 Therapeutic Drug Grant Funding Round of up to $5,000,000 to:
Learn more about the: Funding Criteria for COVID-19 Grant Round
Read the full press release
Your comment will be posted after it is approved.
Leave a Reply.